JPWO2023234166A1 - - Google Patents
Info
- Publication number
- JPWO2023234166A1 JPWO2023234166A1 JP2024524796A JP2024524796A JPWO2023234166A1 JP WO2023234166 A1 JPWO2023234166 A1 JP WO2023234166A1 JP 2024524796 A JP2024524796 A JP 2024524796A JP 2024524796 A JP2024524796 A JP 2024524796A JP WO2023234166 A1 JPWO2023234166 A1 JP WO2023234166A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022089546 | 2022-06-01 | ||
| PCT/JP2023/019470 WO2023234166A1 (ja) | 2022-06-01 | 2023-05-25 | 抗てんかん用組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2023234166A1 true JPWO2023234166A1 (https=) | 2023-12-07 |
Family
ID=89024803
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024524796A Pending JPWO2023234166A1 (https=) | 2022-06-01 | 2023-05-25 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPWO2023234166A1 (https=) |
| WO (1) | WO2023234166A1 (https=) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012017282A (ja) * | 2010-07-07 | 2012-01-26 | Calpis Co Ltd | 迷走神経活性化剤 |
| ES2675811A1 (es) * | 2017-01-12 | 2018-07-12 | Fundación Rioja Salud | Uso de una composición probiótica para el tratamiento complementario de la epilepsia farmacorresistente |
| JP2019172661A (ja) * | 2018-03-28 | 2019-10-10 | 森永乳業株式会社 | ストレス緩和用組成物並びに該ストレス緩和用組成物を用いた医薬品組成物及び飲食品組成物 |
| JP2021503293A (ja) * | 2017-11-20 | 2021-02-12 | ユニバーシティ−インダストリー コーオペレイション グループ オブ キョンヒ ユニバーシティＵｎｉｖｅｒｓｉｔｙ−Ｉｎｄｕｓｔｒｙ Ｃｏｏｐｅｒａｔｉｏｎ Ｇｒｏｕｐ Ｏｆ Ｋｙｕｎｇ Ｈｅｅ Ｕｎｉｖｅｒｓｉｔｙ | 新規乳酸菌及びその用途 |
-
2023
- 2023-05-25 JP JP2024524796A patent/JPWO2023234166A1/ja active Pending
- 2023-05-25 WO PCT/JP2023/019470 patent/WO2023234166A1/ja not_active Ceased
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012017282A (ja) * | 2010-07-07 | 2012-01-26 | Calpis Co Ltd | 迷走神経活性化剤 |
| ES2675811A1 (es) * | 2017-01-12 | 2018-07-12 | Fundación Rioja Salud | Uso de una composición probiótica para el tratamiento complementario de la epilepsia farmacorresistente |
| JP2021503293A (ja) * | 2017-11-20 | 2021-02-12 | ユニバーシティ−インダストリー コーオペレイション グループ オブ キョンヒ ユニバーシティＵｎｉｖｅｒｓｉｔｙ−Ｉｎｄｕｓｔｒｙ Ｃｏｏｐｅｒａｔｉｏｎ Ｇｒｏｕｐ Ｏｆ Ｋｙｕｎｇ Ｈｅｅ Ｕｎｉｖｅｒｓｉｔｙ | 新規乳酸菌及びその用途 |
| JP2019172661A (ja) * | 2018-03-28 | 2019-10-10 | 森永乳業株式会社 | ストレス緩和用組成物並びに該ストレス緩和用組成物を用いた医薬品組成物及び飲食品組成物 |
Non-Patent Citations (1)
| Title |
|---|
| SABOURI S. ET AL.: "Effects of probiotics on pentylenetetrazol-induced convulsions in mice", EPILEPSY RESEARCH, vol. Vol.176, Article 106723, JPN6023032773, 2021, pages 1 - 5, ISSN: 0005646613 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023234166A1 (ja) | 2023-12-07 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240621 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20240621 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250722 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250910 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20251216 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260309 |